Business Context and Reporting Period
Vivos Therapeutics, Inc. (VVOS) filed this Form 8-K on May 23, 2025, reporting events occurring on May 21, 2025. The Company is an emerging growth company incorporated in Delaware, with principal executive offices in Littleton, Colorado. The filing primarily addresses a new financing arrangement to support a pending acquisition.
Key Financial Metrics and Transaction Details
The filing details a specific debt instrument rather than periodic financial performance metrics such as revenue or operating cash flow.
- Instrument: Convertible Promissory Note.
- Principal Amount: $1,100,000.
- Net Proceeds: $1,000,000 (after a $100,000 financing fee).
- Lender: V-CoInvestors 2 LLC (an affiliate of New Seneca Partners Inc.).
- Interest Rate: 0% under normal conditions; 15% per annum upon an Event of Default.
- Security: Unsecured unless an Event of Default occurs, at which point it is secured by fixed assets and equipment.
Material Changes and Transaction Purpose
The primary material change is the entry into a definitive agreement to secure bridge financing. The funds are designated to support the Company's pending acquisition of The Sleep Center of Nevada (the "SCN Acquisition"). The Company expects to close this acquisition no later than July 31, 2025 (the "Outside Date").
Outlook, Management Commentary, and Risks
Conversion Mechanics: The Note is designed to convert automatically into equity on a dollar-to-dollar basis in the event of a "Subsequent Financing" prior to the Outside Date, contingent on the closing of the SCN Acquisition. The Company anticipates such a financing may be led by V-Co.
Repayment Terms: Following the Outside Date, the Company may repay the principal and accrued interest in whole or in part without penalty.
Risks and Contingencies:
- Event of Default: Defined as failure to close the SCN Acquisition by July 31, 2025, failure to pay on demand, breach of covenants, or bankruptcy. Default triggers a 15% interest rate and secures the debt against company assets.
- Regulatory Status: The Note was issued in a private placement exempt from registration under Section 4(a)(2) of the Securities Act. It is not registered and cannot be resold without registration or an exemption.
Investor Verification Checklist
- Verify the status of the pending acquisition of The Sleep Center of Nevada and the likelihood of closing by July 31, 2025.
- Confirm the terms of the anticipated "Subsequent Financing" and whether V-Co will lead the round.
- Review the full text of the Convertible Promissory Note (Exhibit 4.1) and Security Agreement (Exhibit 10.1) for specific covenants and default triggers.
- Assess the Company's current liquidity position relative to the $100,000 financing fee already deducted from the principal.